GNTA US Equity
Genenta Science S.p.A.Health Care · Biological Products, (No Diagnostic Substances) · CIK 1838716$1.22
+0.05 (+4.27%)
USD · as of 2026-08-19 · marketstack
Short interest· FINRA consolidated · settlement 2026-07-31
6 settlement cycles| Shares short | 147K |
| % of shares out | 0.6% |
| Days to cover | 1.9 |
| Δ vs 2026-07-15 | +0.3% |
bars = shares short · line = days to cover (own scale)
| Settlement | Shares short | Δ vs prior | Avg daily volume | Days to cover |
|---|
| 2026-07-31 | 146,513 | +0.3% | 76,399 | 1.9 |
| 2026-07-15 | 145,999 | -12.3% | 99,282 | 1.5 |
| 2026-06-30 | 166,412 | -13.3% | 332,036 | 1.0 |
| 2026-06-15 | 191,896 | -39.3% | 6,417,679 | 1.0 |
| 2026-05-29 | 315,885 | +5048.9% | 1,158,189 | 1.0 |
| 2026-05-15 | 6,135 | -53.9% | 56,976 | 1.0 |
FINRA Rule 4560 · twice monthly, published ~a week later.
Output of a disclosed model — assumptions may be wrong. Research, not investment advice. See the Disclaimer.
